These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10936885)

  • 1. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin and Alzheimer's disease.
    Calero M; Rostagno A; Frangione B; Ghiso J
    Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between multifunctional protein "clusterin" and Alzheimer disease.
    Choi-Miura NH; Oda T
    Neurobiol Aging; 1996; 17(5):717-22. PubMed ID: 8892344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
    Cole GM; Ard MD
    Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.
    Lidström AM; Bogdanovic N; Hesse C; Volkman I; Davidsson P; Blennow K
    Exp Neurol; 1998 Dec; 154(2):511-21. PubMed ID: 9878186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
    Zlokovic BV
    Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
    Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
    Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
    Zlokovic BV; Martel CL; Mackic JB; Matsubara E; Wisniewski T; McComb JG; Frangione B; Ghiso J
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1431-7. PubMed ID: 7802679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
    Thal DR; Ghebremedhin E; Haass C; Schultz C
    Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clusterin: a forgotten player in Alzheimer's disease.
    Nuutinen T; Suuronen T; Kauppinen A; Salminen A
    Brain Res Rev; 2009 Oct; 61(2):89-104. PubMed ID: 19651157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.
    Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB
    Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
    J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain.
    Martin-Rehrmann MD; Hoe HS; Capuani EM; Rebeck GW
    Neurotox Res; 2005; 7(3):231-42. PubMed ID: 15897157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
    Wiesehan K; Buder K; Linke RP; Patt S; Stoldt M; Unger E; Schmitt B; Bucci E; Willbold D
    Chembiochem; 2003 Aug; 4(8):748-53. PubMed ID: 12898626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease.
    Chauhan V; Ji L; Chauhan A
    Biogerontology; 2008 Dec; 9(6):381-9. PubMed ID: 18704746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
    Zlokovic BV; Martel CL; Matsubara E; McComb JG; Zheng G; McCluskey RT; Frangione B; Ghiso J
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4229-34. PubMed ID: 8633046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.